Adaptive Designs in Clinical Trials 2019
April 1 - 2, 2019 - London UKSMi Group
hsidhu@smi-online.co.uk
Phone:0207 827 6088
With the growing popularity in use and acceptance of adaptive designs in clinical trials - demonstrated most recently with the new FDA draft guidance on adaptive designs - there is a pressing need for a forum which explores this increasingly normalized medical methodology. Hosting in depth presentations from regulatory agencies, researchers and biostatisticians, the meeting will cover how personalized medicine, platform trials, response-adaptive randomization, signature designs, estimand framework, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America. The benefits of attending: At this year’s conference there will once again be an array of networking opportunities: • Meet and network with key industry and thought leaders shaping state of the art adaptive design techniques • More than 4 hours of networking during the conference days • Engage with an array of vendors, with leading solution providers, Mevia and GCE Solutions among those exhibiting last year Key reasons to attend: • See how the regulatory environment for adaptive drug design is shifting across the continent with insights from the MHRA, Amgen, AstraZeneca and Berry Consulting • Explore the therapeutic potential of adaptive designs with real-world examples from H.Lundbeck, GSK Vaccines, Pfizer and Novartis • Listen to how the latest platform trial case studies - such as that of the EPAD project and the MS Society initiative, are impacting pharmaceutical development • Delve into the long-standing discussion of Bayesian vs. frequentist designs • Discover the latest research in response-adaptive designs: trials for rare diseases and looking forward EARLY-BIRD RATES: BOOK BY 14th DECEMBER AND SAVE £400 BOOK BY 31ST JANUARY AND SAVE £200 BOOK BY 14H FEBRUARY AND SAVE £100